Tag: Colorectal cancer

Merck, Inspirna join forces to develop first-in-class oral cancer inhibitor

businessnewstoday- January 6, 2024

Merck, a renowned science and technology company, has reached a significant milestone in its efforts to combat cancer. The company announced a strategic licensing agreement ... Read More

Exscientia begins enrollment for Phase 1/2 cancer trial of CDK7 inhibitor

businessnewstoday- July 11, 2023

AI-driven precision medicine company Exscientia has initiated enrollment for its Phase 1/2 "ELUCIDATE" study, marking the first trial of its precision-designed CDK7 inhibitor, GTAEXS617 ('617), ... Read More

Natco Pharma wins FDA approval for generic colorectal cancer drug

businessnewstoday- June 16, 2023

Indian pharmaceutical firm Natco Pharma has gained the US Food and Drug Administration (FDA)'s final approval for its abbreviated new drug application (ANDA) for Tipiracil ... Read More

Lupin, Enzene Biosciences to launch cancer drug Cetuximab biosimilar in India

businessnewstoday- May 31, 2023

Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is ... Read More

Takeda signs licensing deal for Hutchmed’s fruquintinib outside of China

Raghuram Kadari- January 24, 2023

Takeda Pharmaceutical will acquire an exclusive worldwide license, excluding China, of fruquintinib from Hutchmed (China) and its subsidiary Hutchmed to strengthen its oncology portfolio. Under ... Read More

Seagen gets FDA accelerated approval for tucatinib, trastuzumab combo for colorectal cancer

Raghuram Kadari- January 21, 2023

American biotechnology company Seagen (formerly Seattle Genetics) has received accelerated approval from the US Food and Drug Administration (FDA) for the company’s oral drug Tukysa ... Read More

Biomea Fusion to take BMF-219 into clinical trials for KRAS solid tumors

businessnewstoday- October 16, 2022

Biomea Fusion is all set to take BMF-219 into clinical trials in patients having unresectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC), colorectal ... Read More

MedGenome says cancer vaccine approach can help in Lynch Syndrome treatment

pharmanewsdaily- September 15, 2018

MedGenome, an Indian genomics research and diagnostics startup, in a recent study has found out that using a cancer vaccine approach can be applied in ... Read More